(Q34106112)

31 July 2017

title

Recurrence of macular edema associated with branch retinal vein occlusion after intravitreal bevacizumab (English)

1 reference

31 July 2017

1 reference

retinal vein occlusion

1 reference

Narihisa Hanada

1

1 reference

31 July 2017

Hiroyuki Iijima

series ordinal

2

1 reference

31 July 2017

Yoichi Sakurada

series ordinal

3

1 reference

31 July 2017

Mitsuhiro Imasawa

series ordinal

4

1 reference

31 July 2017

publication date

20 December 2011

1 reference

Japanese Journal of Ophthalmology

31 July 2017

published in

1 reference

31 July 2017

volume

56

1 reference

31 July 2017

issue

2

1 reference

31 July 2017

page(s)

165-174

1 reference

Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6.

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10384-011-0113-4

The effects of intravitreal bevacizumab on patients with macular edema secondary to branch retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10384-011-0113-4

Safety and efficacy of intravitreal bevacizumab (avastin) for the management of branch and hemiretinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10384-011-0113-4

One-year results after intravitreal bevacizumab therapy for macular edema secondary to branch retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10384-011-0113-4

Intravitreal injection of bevacizumab for macular edema secondary to branch retinal vein occlusion:results after 12 months and multiple regression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10384-011-0113-4

Intravitreal bevacizumab for the treatment of macular oedema secondary to branch retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10384-011-0113-4

Visual acuity following intravitreal bevacizumab for macular edema associated with retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10384-011-0113-4

Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10384-011-0113-4

Early intravitreal bevacizumab for non-ischaemic branch retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10384-011-0113-4

Bevacizumab compared with macular laser grid photocoagulation for cystoid macular edema in branch retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10384-011-0113-4

Intravitreal triamcinolone acetonide versus bevacizumab therapy for macular edema associated with branch retinal vein occlusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10384-011-0113-4

Intravitreal triamcinolone acetonide vs bevacizumab for treatment of macular oedema secondary to branch retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10384-011-0113-4

Comparison of bevacizumab and triamcinolone for treatment of macular edema secondary to branch retinal vein occlusion in a pair-matched analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10384-011-0113-4

Comparison between intravitreal bevacizumab and triamcinolone for macular edema secondary to branch retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10384-011-0113-4

The treatment of branch retinal vein occlusion with bevacizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10384-011-0113-4

Long-term follow-up of OCT-guided bevacizumab treatment of macular edema due to retinal vein occlusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10384-011-0113-4

Risks of intravitreous injection: a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10384-011-0113-4

Sterile endophthalmitis after intravitreal injection of bevacizumab obtained from a single batch

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10384-011-0113-4

Topography of diabetic macular edema with optical coherence tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10384-011-0113-4

Sectoral thinning of the retina after branch retinal artery occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10384-011-0113-4

Predictive factors for changes in macular edema in intravitreal bevacizumab therapy of retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10384-011-0113-4

Intravitreal bevacizumab (Avastin) for macular oedema secondary to retinal vein occlusion: 12-month results of a prospective clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10384-011-0113-4

Effect of intravitreal bevacizumab (IVB) in treating macular edema secondary to branch retinal vein occlusion (BRVO).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10384-011-0113-4

Intravitreal bevacizumab versus triamcinolone acetonide for macular edema due to branch retinal vein occlusion: a matched study

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22183139

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Rebound macular edema following bevacizumab (Avastin) therapy for retinal venous occlusive disease

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22183139

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Argon laser photocoagulation for macular edema in branch vein occlusion. The Branch Vein Occlusion Study Group

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22183139

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S10384-011-0113-4

1 reference

Dimensions Publication ID

31 July 2017

1045673853

0 references

1 reference